Showing 1,681 - 1,700 results of 102,372 for search '(( 12 mg decrease ) OR ( 5 ((((we decrease) OR (a decrease))) OR (teer decrease)) ))', query time: 0.94s Refine Results
  1. 1681

    Astrocytosis is decreased in the brains of 5XFAD/<i>LDLR</i>-/- and 5XFAD/<i>ApoE-/- LDLR</i>-/- mice. by Loukia Katsouri (348708)

    Published 2013
    “…Quantitation of GFAP positive staining in the hippocampi and cortices showing a decrease in the 5XFAD/<i>LDL</i>-/- and 5XFAD/<i>ApoE</i>-/-<i>LDLR</i>-/- mice compared to the control mice. …”
  2. 1682
  3. 1683
  4. 1684
  5. 1685
  6. 1686
  7. 1687
  8. 1688
  9. 1689
  10. 1690

    Do we treat our patients or rather periodontal microbes with adjunctive antibiotics in periodontal therapy? A 16S rDNA microbial community analysis by Daniel Hagenfeld (319909)

    Published 2018
    “…We found statistically noticeable decreased richness, and increased dissimilarity in the antibiotic, but not in the placebo group after therapy. …”
  11. 1691
  12. 1692
  13. 1693
  14. 1694
  15. 1695
  16. 1696

    Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress by Béatrice Chambraud (3371201)

    Published 2021
    “…In this study, we demonstrate that FKBP4 decrease in a human neuronal cell line (SH-SY5Y) and in dorsal root ganglion (DRG) neurons from human MAPT<sup>P301S</sup> transgenic mice affected the function of the autophagy-lysosomal system under MAPT induced proteotoxic stress conditions. …”
  17. 1697
  18. 1698
  19. 1699
  20. 1700

    Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

    Published 2022
    “…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”